Evidence map›Paper›PMID 40406248›Full record

ArticleFrontiers in oncology2025

Development and validation of a predictive model combining radiomics and deep learning features for spread through air spaces in stage T1 non-small cell lung cancer: a multicenter study.

Pengliang Xu, Huanming Yu, Wenjian Xing, Shiyu Zhang, Haihua Hu, Wenhui Li, Dan Jia, Shengxu Zhi, Xiuhua Peng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pengliang Xu *Department of Thoracic Surgery, The First People's Hospital of Huzhou, Huzhou, China.
Huanming Yu *Department of Thoracic Surgery, The First People's Hospital of Huzhou, Huzhou, China.
Wenjian XingDepartment of Radiology, Linghu Hospital, Second Medical Group of Nanxun District, Huzhou, China.
Shiyu ZhangDepartment of Radiology, Xishan People's Hospital of Wuxi, Wuxi, China.
Haihua HuDepartment of Radiology, Zhebei Mingzhou Hospital of Huzhou, Huzhou, China.
Wenhui LiDepartment of Thoracic Surgery, The First People's Hospital of Huzhou, Huzhou, China.
Dan JiaDepartment of Respiratory Medicine, The First People's Hospital of Huzhou, Huzhou, China.
Shengxu ZhiDepartment of Thoracic Surgery, The First People's Hospital of Huzhou, Huzhou, China.
Xiuhua PengDepartment of Radiology, The First People's Hospital of Huzhou, Huzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The goal of this paper is to compare the effectiveness of three deep learning models (2D, 3D, and 2.5D), three radiomics models(INTRA, Peri2mm, and Fusion2mm), and a combined model in predicting the spread through air spaces (STAS) in non-small cell lung cancer (NSCLC) to identify the optimal model for clinical surgery planning. Methods: We included 480 patients who underwent surgery at four centers between January 2019 and August 2024, dividing them into a training cohort, an internal test cohort, and an external validation cohort. We extracted deep learning features using the ResNet50 algorithm. Least absolute shrinkage selection operator(Lasso) and spearman rank correlation were utilized to choose features. Extreme Gradient Boosting (XGboost) was used to execute deep learning and radiomics. Then, a combination model was developed, integrating both sources of data. Result: The combined model showed outstanding performance, with an area under the receiver operating characteristic curve (AUC) of 0.927 (95% CI 0.870 - 0.984) in the test set and 0.867 (95% CI 0.819 - 0.915) in the validation set. This model significantly distinguished between high-risk and low-risk patients and demonstrated significant advantages in clinical application. Conclusion: The combined model is adequate for preoperative prediction of STAS in patients with stage T1 NSCLC, outperforming the other six models in predicting STAS risk.

Indexed as

artificial intelligencedeep learninglung adenocarcinomaradiomicsSTAS

Identifiers

PMID40406248
PMCPMC12094994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.